Avantor (NYSE:AVTR) & Auna (NYSE:AUNA) Financial Contrast

Avantor (NYSE:AVTR) and Auna (NYSE:AUNA) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, valuation, risk, analyst recommendations and earnings.

Profitability

This table compares Avantor and Auna’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Avantor	-8.42%	9.95%	4.78%
Auna	1.53%	16.25%	4.03%

Analyst Ratings

This is a breakdown of current recommendations and price targets for Avantor and Auna, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avantor	3	12	2	0	1.94
Auna	1	2	1	1	2.40

Avantor presently has a consensus target price of $10.62, indicating a potential upside of 4.83%. Auna has a consensus target price of $6.97, indicating a potential upside of 34.88%. Given Auna’s stronger consensus rating and higher possible upside, analysts clearly believe Auna is more favorable than Avantor.

Insider & Institutional Ownership

95.1% of Avantor shares are held by institutional investors. 0.3% of Avantor shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Volatility and Risk

Avantor has a beta of 0.94, suggesting that its share price is 6% less volatile than the S&P 500. Comparatively, Auna has a beta of 0.62, suggesting that its share price is 38% less volatile than the S&P 500.

Earnings and Valuation

This table compares Avantor and Auna”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avantor	$6.55 billion	1.06	-$530.20 million	($0.81)	-12.51
Auna	$1.23 billion	0.31	$27.39 million	$0.26	19.87

Auna has lower revenue, but higher earnings than Avantor. Avantor is trading at a lower price-to-earnings ratio than Auna, indicating that it is currently the more affordable of the two stocks.

Summary

Auna beats Avantor on 8 of the 15 factors compared between the two stocks.

About Avantor

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

About Auna

Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. The company was founded in 1989 and is based in Luxembourg, Luxembourg.